Atypical hypothyroidism and the very low birthweight infant

S J Mandel1, R J Hermos, C A Larson

  • 1Division of Endocrinology, Diabetes and Metabolism, University of Pennsylvania, Philadelphia, USA. smandel@mail.med.upenn.edu

Insights

Newborn screening for hypothyroidism reveals higher incidence in very low birthweight infants. Atypical cases, missed by TSH-only screening, necessitate routine T4 testing for these vulnerable infants.

Area of Science:

  • Neonatal screening
  • Endocrinology
  • Public health

Background:

  • Thyroid dysfunction in newborns can have significant developmental consequences.
  • Standard newborn screening protocols primarily rely on thyrotropin (TSH) levels.

Purpose of the Study:

  • To retrospectively analyze the incidence and characteristics of congenital hypothyroidism in a large infant cohort.
  • To evaluate the effectiveness of current screening methods for detecting both typical and atypical hypothyroidism, particularly in relation to birth weight.

Main Methods:

  • Retrospective analysis of thyroid screening test results from 311,282 infants born between 1993 and 1996.
  • Categorization of infants based on birth weight: normal (NBW), low (LBW), and very low (VLBW).
  • Definition and identification of typical (low T4, elevated TSH) and atypical (low T4, normal initial TSH, elevated repeat TSH) hypothyroidism.

Main Results:

  • The incidence of hypothyroidism was significantly higher in lower birth weight categories (LBW: 1:1589, VLBW: 1:153) compared to normal birth weight (NBW: 1:3051).
  • Atypical hypothyroidism was disproportionately found in VLBW infants (48% of VLBW cases, 56% of all atypical cases).
  • Primary TSH screening alone may miss cases of atypical hypothyroidism.

Conclusions:

  • Very low birth weight infants exhibit the highest incidence of congenital hypothyroidism.
  • Current screening protocols may fail to detect atypical hypothyroidism, especially in VLBW infants.
  • Routine thyroxine (T4) measurements and repeat blood specimens are recommended for all low and very low birth weight infants to improve detection rates.

Related Concept Videos

Synthesis and Regulation of Thyroid Hormones01:20

Synthesis and Regulation of Thyroid Hormones

Low blood levels of the thyroid hormones — triiodothyronine (T3) and thyroxine (T4) — signal the hypothalamus to release the thyrotropin-releasing hormone (TRH). TRH then reaches the pituitary gland and stimulates the release of thyroid-stimulating hormone(TSH) into the bloodstream.
Upon reaching the thyroid gland, TSH stimulates the follicular cells' active uptake of iodide ions from the blood. The ions diffuse to the apical surface of the cells and are oxidized to iodine. The iodine is then...
Hyperthyroidism I: Introduction01:25

Hyperthyroidism I: Introduction

Hyperthyroidism is a type of thyrotoxicosis characterized by the thyroid gland's overproduction of the thyroid hormones triiodothyronine (T3) and thyroxine (T4). This hormone excess increases the basal metabolic rate and enhances sensitivity to catecholamines.DiagnosisDiagnosis is based on clinical features and biochemical testing. It typically shows suppressed thyroid-stimulating hormone (TSH) levels below 0.4 mIU/L, with elevated free T3 and/or T4. Additional tests, including thyroid...
Hyperthyroidism II: Pathophysiology01:27

Hyperthyroidism II: Pathophysiology

Hyperthyroidism is a hypermetabolic state caused by elevated levels of thyroid hormones, triiodothyronine (T3) and thyroxine (T4). It results from dysregulation at the thyroid, pituitary, or immune system level and affects multiple organ systems.PathophysiologyThe most common cause of hyperthyroidism is Graves’ disease, an autoimmune disorder in which antibodies, specifically thyroid-stimulating antibodies (TSAb), a subtype of TSH receptor antibodies (TRAb), bind to and activate TSH receptors...
Graves' Disease I: Introduction01:28

Graves' Disease I: Introduction

Graves' disease is an autoimmune disorder that causes hyperthyroidism, or overactivity of the thyroid gland. It results from autoantibodies called thyroid-stimulating immunoglobulins (TSIs), which bind to thyroid-stimulating hormone (TSH) receptors, leading to overstimulation of hormone production and a hypermetabolic state.EtiologyAlthough considered idiopathic, Graves’ disease has well-established contributing factors. There is a strong genetic component, with increased prevalence in...
Graves Disease II: Pathophysiology01:24

Graves Disease II: Pathophysiology

Graves’ disease is an autoimmune disorder characterized by the production of thyroid-stimulating immunoglobulins (TSI) that activate TSH receptors, leading to excessive synthesis and release of thyroid hormones (T3 and T4) and resulting in hyperthyroidism.Among all causes of hyperthyroidism, Graves’ disease is the most common and can happen at any age, though it is more frequent in women. It produces a hypermetabolic state with features such as weight loss, tachycardia, tremor, and heat...
Hypothyroidism II: Pathophysiology01:23

Hypothyroidism II: Pathophysiology

Hypothyroidism is a disorder characterized by insufficient production of thyroid hormones, which regulate metabolism, energy balance, and multiple organ systems.TypesHypothyroidism is classified based on the level of dysfunction. Primary hypothyroidism results from intrinsic thyroid gland dysfunction, causing reduced hormone production despite normal or increased stimulation. Secondary hypothyroidism arises from inadequate thyroid-stimulating hormone (TSH) secretion by the pituitary. Tertiary...